Skip to main content

Table 1 Regensburg registry and other published trials and registries including patients treated by the MitraClip system

From: 3D vena contracta area after MitraClip© procedure: precise quantification of residual mitral regurgitation and identification of prognostic information

 

Regensburg

GRASP [17]

TRAMI [19]

MitraSWISS [18]

Pilot Registry [21]a

ACCESS-EU [20]

EVEREST-II [1]

Year of publication

 

2016

2016

2014

2014

2013

2011

Participants

102

180

749

74

628

567

184

Female [%]

42.2

38.3

38.6

27

36.9

36.2

38

Age [years]

77.0 ± 5.8

71.6 ± 9.8

76 (10)b

72 ± 12

74.2 ± 9.7

73.7 ± 9.6

67.3 ± 12.8

MR grade III/IV [%]

100

93.8

100

86.1c

97.7

96

DMR [%]

28.4

18.3

27.8

38

22.8

20.6

74

FMR [%]

71.6

81.7

71.3

62

72.0

69.3

27

NYHA III/IV [%]

75.5

81.1

89

85.5

84.9

52

EuroScore II

5.1 ± 5.9

7.6 ± 6.4

LogEuroScore [%]

26.6 ± 18.0

20 (19)f

21 ± 17

20.4 ± 16.7

23.0 ± 18.3

Regurgitant orifice area [cm2]

0.40 ± 0.18

0.43 ± 0.16

0.56 ± 0.38

  1. Shown are mean and standard deviation or proportions (if not indicated otherwise)
  2. aTranscatheter Valve Treatment Sentinel Pilot Registry, bmedian (IQR), csevere (graded as mild, moderate, severe). MR mitral regurgitation, DMR degenerative mitral regurgitation, FMR functional mitral regurgitation, NYHA New York Heart Association functional classification